Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease (KAT301)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Eastern Finland
Information provided by (Responsible Party):
Juha Hartikainen, Kuopio University Hospital
ClinicalTrials.gov Identifier:
NCT01002430
First received: October 23, 2009
Last updated: March 1, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)